Skip to main content

Coumadin and Kidney Cancer

  • Chapter
Renal Cell Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Caine, G. J., P. S. Stonelake, et al. (2002). The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 4(6): 465–473.

    Article  PubMed  CAS  Google Scholar 

  • De Cicco, M. (2004). The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 50(3): 187–196.

    Article  PubMed  Google Scholar 

  • Deitcher, S. R. (2003). Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies. Semin Thromb Hemost 29(3): 247–258.

    Article  PubMed  Google Scholar 

  • Donati, M. B. (1995). Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice. Thromb Haemost 74(1): 278–281.

    PubMed  CAS  Google Scholar 

  • Dotan, Z. A., Y. Mor, et al. (2002). The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 168(2): 610–613; discussion 614.

    Article  PubMed  CAS  Google Scholar 

  • Douketis, J. D. (2002). Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 108(1): 3–13.

    Article  PubMed  Google Scholar 

  • Douketis, J. D., J. A. Johnson, et al. (2004). Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 164(12): 1319–1326.

    Article  PubMed  CAS  Google Scholar 

  • Dunn, A. S. and A. G. Turpie. (2003). Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 163(8): 901–908.

    Article  PubMed  Google Scholar 

  • Dunn, M. D., A. J. Portis, et al. (2000). Laparoscopic versus open radical nephrectomy: a 9-year experience. J Urol 164(4): 1153–1159.

    Article  PubMed  CAS  Google Scholar 

  • Forster, Y., A. Meye, et al. (2003). Tissue specific expression and serum levels of human tissue factor in patients with urological cancer. Cancer Lett 193(1): 65–73.

    Article  PubMed  CAS  Google Scholar 

  • Garcia, D. A., W. Ageno, et al. (2004). Perioperative anticoagulation for patients with mechanical heart valves: a survey of current practice. J Thromb Thrombolysis 18(3): 199–203.

    Article  PubMed  Google Scholar 

  • Gill, I. S., E. M. Remer, et al. (2005). Renal cryoablation: outcome at 3 years. J Urol 173(6): 1903–1907.

    Article  PubMed  Google Scholar 

  • Gordon, S. G., J. J. Franks, et al. (1979). Comparison of procoagulant activities in extracts of normal and malignant human tissue. J Natl Cancer Inst 62(4): 773–776.

    PubMed  CAS  Google Scholar 

  • Jafri, S. M. and T. P. Metha. (2004). Periprocedural management of anticoagulation in patients on extended warfarin therapy. Semin Thromb Hemost 30(6): 657–664.

    Article  PubMed  CAS  Google Scholar 

  • Johnson, M. J., M. W. Sproule, et al. (1999). The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer. Clin Oncol (R Coll Radiol) 11(2): 105–110.

    CAS  Google Scholar 

  • Kearon, C. and J. Hirsh. (1997). Management of anticoagulation before and after elective surgery. N Engl J Med 336(21): 1506–1511.

    Article  PubMed  CAS  Google Scholar 

  • Kim, F. J., K. H. Rha, et al. (2003). Laparoscopic radical versus partial nephrectomy: assessment of complications. J Urol 170(2 Pt 1): 408–411.

    Article  PubMed  Google Scholar 

  • Lee, A. Y. (2002). Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev 28(3): 137–140.

    Article  PubMed  CAS  Google Scholar 

  • Levitan, N., A. Dowlati, et al. (1999). Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78(5): 285–291.

    Article  CAS  Google Scholar 

  • Link, R. E., S. B. Bhayani, et al. (2005). Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol 173(5): 1690–1694.

    Article  PubMed  Google Scholar 

  • Mandala, M., G. Ferretti, et al. (2003). Venous thromboembolism and cancer: new issues for an old topic. Crit Rev Oncol Hematol 48(1): 65–80.

    Article  PubMed  Google Scholar 

  • Mulcahy, J. J., R. O. Bradenburg, et al. (1975). Transurethral prostatic resection in patients with prosthetic cardiac valves. J Urol 113(5): 642–643.

    PubMed  CAS  Google Scholar 

  • Nachman, R. L. and K. A. Hajjar. (1991). Endothelial cell fibrinolytic assembly. Ann NY Acad Sci 614: 240–249.

    Article  PubMed  CAS  Google Scholar 

  • Novick, A. C. (2004). Laparoscopic and partial nephrectomy. Clin Cancer Res 10(18 Pt 2): 6322S–6327S.

    Article  PubMed  Google Scholar 

  • Parr, N. J., C. S. Loh, et al. (1989). Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol 64(6): 623–625.

    Article  PubMed  CAS  Google Scholar 

  • Ramani, A. P., M. M. Desai, et al. (2005). Complications of laparoscopic partial nephrectomy in 200 cases. J Urol 173(1): 42–47.

    PubMed  Google Scholar 

  • Rickles, F. R. and M. N. Levine. (1998). Venous thromboembolism in malignancy and malignancy in venous thromboembolism. Haemostasis 28 Suppl 3: 43–49.

    Article  CAS  Google Scholar 

  • Sampson, M. T. and A. K. Kakkar. (2002). Coagulation proteases and human cancer. Biochem Soc Trans 30(2): 201–207.

    Article  PubMed  CAS  Google Scholar 

  • Shuford, M. D., E. M. McDougall, et al. (2004). Complications of contemporary radical nephrectomy: comparison of open vs. laparoscopic approach. Urol Oncol 22(2): 121–126.

    PubMed  Google Scholar 

  • Simon, S. D., E. P. Castle, et al. (2004). Complications of laparoscopic nephrectomy: the Mayo Clinic experience. J Urol 171(4): 1447–1450.

    Article  PubMed  Google Scholar 

  • Spyropoulos, A. C. (2005). Perioperative bridging therapy for the at-risk patient on chronic anticoagulation. Dis Mon 51(2-3):183–193.

    Article  PubMed  Google Scholar 

  • Thodiyil, P. A., D. C. Walsh, et al. (2001). Thromboprophylaxis in the cancer patient. Acta Haematol 106(1-2): 73–80.

    Article  PubMed  CAS  Google Scholar 

  • Trousseau, A. (1865). Phlegmasia alba dolens. Clinique Medicale de l’Hotel-Dieu de Paris. London: The New Syndeham Society 3:94–99.

    Google Scholar 

  • Tscholl, R., W. Straub, et al. (1980). Electroresection of the prostate in patients treated with heparin. J Urol 124(2): 221–222.

    PubMed  CAS  Google Scholar 

  • Varkarakis, I. M., S. Rais-Bahrami, et al. (2005). Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy. J Urol 174(3): 1020–1023; discussion 1023.

    Article  PubMed  Google Scholar 

  • Walsh-McMonagle, D. and D. Green. (1997). Low-molecular-weight heparin in the management of Trousseau’s syndrome. Cancer 80(4): 649–655.

    Article  PubMed  CAS  Google Scholar 

  • Zacharski, L. R., V. A. Memoli, et al. (1986). Coagulation-cancer interaction in situ in renal cell carcinoma. Blood 68(2): 394–399.

    PubMed  CAS  Google Scholar 

  • Zacharski, L. R., D. L. Ornstein, et al. (1998). Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb Haemost 79(4): 876–877.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Liou, L.S., Kheterpal, E., Babayan, R.K. (2008). Coumadin and Kidney Cancer. In: Rosette, J.J.d., Sternberg, C.N., Poppel, H.P.v. (eds) Renal Cell Cancer. Springer, London. https://doi.org/10.1007/978-1-84628-763-3_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-763-3_39

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-385-7

  • Online ISBN: 978-1-84628-763-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics